BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3000906)

  • 1. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA; Stein LD; Dosch HM; Sigal NH
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
    Hibi T; Chan MA; Petsche D; Dosch HM
    J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    Tosato G; Blaese RM; Yarchoan R
    J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.
    Aman P; Gordon J; Lewin N; Nordström M; Ehlin-Henriksson B; Klein G; Carstensson A
    J Immunol; 1985 Oct; 135(4):2362-7. PubMed ID: 2993411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
    Brown NA; Miller G
    J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution.
    Miyawaki T; Kubagawa H; Butler JL; Cooper MD
    J Immunol; 1988 Jun; 140(11):3887-92. PubMed ID: 2836502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
    Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
    Ling NR; Lowe JA
    Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotype commitment of human B cells that are transformed by Epstein-Barr virus.
    Miyawaki T; Butler JL; Radbruch A; Gartland GL; Cooper MD
    Eur J Immunol; 1991 Jan; 21(1):215-20. PubMed ID: 1846818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
    Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
    J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.
    Golay JT; Crawford DH
    Immunology; 1987 Oct; 62(2):279-84. PubMed ID: 2824347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
    Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
    J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting dilution analysis of the B cell compartment in human bone marrow.
    Hibi T; Dosch HM
    Eur J Immunol; 1986 Feb; 16(2):139-45. PubMed ID: 2869953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    Conley ME; Chan MA; Sigal NH
    J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of human colostrum lymphocytes with Epstein-Barr virus and the production of IgA in culture.
    Maeda-Takekoshi F; Takekoshi M; Tanaka S; Watanabe Y; Dosako S; Kikuchi E
    Tokai J Exp Clin Med; 1984 Jun; 9(2):103-8. PubMed ID: 6100146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
    Kim YS; Park GB; Choi YM; Kwon OS; Song HK; Kang JS; Kim YI; Lee WJ; Hur DY
    Hum Immunol; 2006 Oct; 67(10):795-807. PubMed ID: 17055356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.